Form 8-K - Current report:
SEC Accession No. 0001193125-17-377415
Filing Date
2017-12-22
Accepted
2017-12-22 13:01:03
Documents
8
Period of Report
2017-12-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d515063d8k.htm 8-K 20953
2 EX-1.1 d515063dex11.htm EX-1.1 166513
3 EX-5.1 d515063dex51.htm EX-5.1 9583
4 EX-99.1 d515063dex991.htm EX-99.1 9344
5 EX-99.2 d515063dex992.htm EX-99.2 8849
6 GRAPHIC g515063dsp6.jpg GRAPHIC 1504
7 GRAPHIC g515063g1222122930579.jpg GRAPHIC 2497
8 GRAPHIC g515063g79a22.jpg GRAPHIC 1852
  Complete submission text file 0001193125-17-377415.txt   224970
Mailing Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080 6507450655
CATALYST BIOSCIENCES, INC. (Filer) CIK: 0001124105 (see all company filings)

EIN.: 562020050 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51173 | Film No.: 171272065
SIC: 2834 Pharmaceutical Preparations